Pharmacy Daily | Nature’s Own launches EQ Control with clinically trialled Sensoril

Other recent headlines

• 

  Joint call for funding GP-based pharmacists

  Thursday | May 1 2025

  THE Pharmaceutical Society of Australia (PSA) and Royal Australian College of GPs (RACGP) and have joined forces to call on major parties to fund general practice-based pharmacists to work with specialist GPs to support high-quality prescribing and quality use of medicines.

  
• 

  First new PBS listing for ALS drug in 20 yrs

  Thursday | May 1 2025

  RADICAVA IV infusion (edaravone, Teva Pharma) is now listed on the Pharmaceutical Benefits Scheme (PBS) for eligible adults with amyotrophic lateral sclerosis (ALS), representing the first new PBS-listed molecule for the treatment of ALS in over 20 years.

  
• 

  New Bioderma brand identity aims to highlight skin health

  Thursday | May 1 2025

  A NEW visual identity designed to reflect Bioderma’s 45-year legacy of dermatological innovation has been launched by the French skincare brand.